9/19
09:21 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $300.00 price target on the stock.
Medium
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $300.00 price target on the stock.
9/19
09:21 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $300.00 price target on the stock.
Medium
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $300.00 price target on the stock.
9/19
09:03 am
alny
Rating for ALNY
Medium
Report
Rating for ALNY
9/19
09:03 am
alny
Rating for ALNY
Medium
Report
Rating for ALNY
9/9
12:14 pm
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $220.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $220.00 price target on the stock.
9/9
11:09 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
9/4
10:05 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $300.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $300.00 price target on the stock.
9/4
10:05 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $300.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $300.00 price target on the stock.
9/4
09:30 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
9/4
09:30 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
8/30
02:14 pm
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $400.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $400.00 price target on the stock.
8/26
10:40 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
8/20
08:05 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $400.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $400.00 price target on the stock.
8/16
10:30 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
8/16
10:30 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
8/16
10:30 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
8/2
03:43 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
8/2
03:43 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
8/2
02:33 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
8/2
02:33 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
8/2
01:45 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
8/2
01:45 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
8/2
12:22 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
8/2
12:22 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
8/2
12:22 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY